Financials
Financial year 2025
BOSLY ENDOCRINOLOGIE ET NUTRITION from Arlon, company number BE0820413231, closed financial year 2025 with a result of € 102,219 after tax. For that financial year BOSLY ENDOCRINOLOGIE ET NUTRITION recorded a gross margin of € 130,994 and equity of € 939,288. Compared with financial year 2024, the result moved from € 86,320 to € 102,219. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 7, 2026.
€ 939,288
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 102,219
▲ 18% vs 2024
Profit after tax over the fiscal year.
€ 165,647
▲ 234% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 833 paid out
1 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 602
▲ 82% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 601
▲ 176% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 43,424
▲ 11% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 111,041 | € 122,192 | € 116,330 | € 130,994 | ▲ 13% |
| Profit after taxes | € 76,405 | € 79,570 | € 86,320 | € 102,219 | ▲ 18% |
| Equity | € 723,645 | € 802,416 | € 837,903 | € 939,288 | ▲ 12% |
| Total debts | € 38,815 | € 42,334 | € 44,483 | € 46,571 | ▲ 5% |
| Cash | € 414,420 | € 125,333 | € 49,639 | € 165,647 | ▲ 234% |
| Land & buildings | € 127,028 | € 120,886 | € 114,743 | € 108,601 | ▼ 5% |
| Retained profit | € 603,172 | € 669,285 | € 704,773 | € 806,158 | ▲ 14% |
| Dividend | € 800 | € 800 | € 50,833 | € 833 | ▼ 98% |
| Bank debt | € 1,150 | € 1,150 | € 1,150 | € 0 | ▼ 100% |
| Balance sheet total | € 762,460 | € 844,749 | € 882,385 | € 985,860 | ▲ 12% |
By gross margin, BOSLY ENDOCRINOLOGIE ET NUTRITION ranks 7th of 11 companies with main activity “Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied” in the province of Luxembourg that publish figures (fiscal year 2025).
Key figures of BOSLY ENDOCRINOLOGIE ET NUTRITION, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about BOSLY ENDOCRINOLOGIE ET NUTRITION the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to BOSLY ENDOCRINOLOGIE ET NUTRITION?
What happened at BOSLY ENDOCRINOLOGIE ET NUTRITION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 102,219 (▲ 18% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Arlon. KBO
In short
From € 76,405 profit in 2022 to € 102,219 profit in 2025.
Paid € 139,644 in corporate taxes since 2022.
Best year ever: 2025, with € 102,219 profit.
Paid out € 53,266 in dividends to the owners in total.
Management
Behind BOSLY ENDOCRINOLOGIE ET NUTRITION is Florence BOSLY.
Directors
According to the 2025 annual accounts
Florence BOSLY
Manager
Establishments
Establishment units
Physical locations of this company
Udange, rue de Habergy 30
6700 Arlon
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in the province of Luxembourg
Same main activity (Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied), 15 active companies in the province of Luxembourg, largest first.
€ 22.4 million revenue · 2025 · Marche-en-Famenne
€ 3.4 million revenue · 2025 · Marche-en-Famenne
Centre agri-environnemental de Michamps
€ 1.4 million gross margin · 2025 · Bastogne
Biotope Environnement - Biotope Natuur
€ 1.1 million gross margin · 2025 · Etalle
€ 404,140 gross margin · 2024 · Libramont-Chevigny
€ 167,199 gross margin · 2025 · Arlon
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- BOSLY Florence Agnès Françoise Jacqueline Marianne(oprichter) 100%
Details
- Company number
- 0820.413.231
- VAT number
- BE 0820.413.231
- Registered office
- Udange, rue de Habergy 30, 6700 Arlon
- Names & denominations
- BOSLY ENDOCRINOLOGIE ET NUTRITION · "B.E.N" S.R.L
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 November 2009
- Peppol
- Active · Active since 26 Sept 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied